The chemical class of Dok-1 Activators comprises compounds that can indirectly influence the activity of Dok-1 by targeting various signaling pathways associated with cell signaling and immune response. These activators work through diverse mechanisms, impacting Dok-1 activity by altering the signaling elements upstream or downstream of pathways in which Dok-1 is involved. Compounds like Forskolin, adenosine receptor agonists, and AMPK activators enhance Dok-1 signaling indirectly by modulating cAMP-dependent pathways and metabolic signaling, which play crucial roles in immune cell signaling and responses. mTOR activators, NF-κB activators, and GPCR agonists, such as MHY1485, Prostratin, and Epinephrine, can indirectly affect Dok-1's function in immune regulation and signaling by modulating these pathways.
Other notable compounds in this class include PI3K activators, glucocorticoid receptor agonists, and calcium channel activators, each affecting different aspects of immune regulation and signaling. By modulating these pathways, these activators can indirectly enhance Dok-1's function in cell signaling processes. Additionally, compounds like GSK3β activators, HSP90 activators, and TLR agonists demonstrate the ability to activate Dok-1 through their influence on GSK3β activity, protein stability, and toll-like receptor pathways. In summary, the Dok-1 Activators class encompasses compounds with diverse mechanisms of action, all converging on the modulation of cell signaling and immune response pathways. By targeting upstream elements of these pathways or indirectly influencing Dok-1 activity through pathway interactions and signaling cross-talk.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can activate PKA and potentially enhance Dok-1 signaling by modulating related pathways in immune cells. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activating adenosine receptors can lead to increased cAMP levels, potentially enhancing Dok-1 signaling indirectly via cAMP-dependent pathways. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
AMPK activators like Metformin may influence Dok-1 indirectly by modulating metabolic and inflammatory pathways that intersect with Dok-1 signaling. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
Activating mTOR can influence immune cell function and cytokine signaling, potentially enhancing Dok-1 activity indirectly through related signaling pathways. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
NF-κB activators might enhance Dok-1 signaling indirectly by upregulating inflammatory pathways that interact with Dok-1 signaling. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
GPCR agonists like Epinephrine, through cAMP elevation, can potentially enhance Dok-1 signaling indirectly in immune-related pathways. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Activating glucocorticoid receptors can modulate immune responses, potentially influencing Dok-1 signaling indirectly through anti-inflammatory pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Calcium channel activators might indirectly enhance Dok-1 by altering calcium signaling, which can intersect with Dok-1 mediated pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK3β activators could affect Dok-1 indirectly by modulating GSK3β activity, which may interact with Dok-1 in signaling pathways. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 activators might indirectly enhance Dok-1 by affecting protein folding and stability, impacting proteins that interact with Dok-1 in cellular signaling. | ||||||